Featured Stories

Native Hosts Invite-Only Side Event at Paris Blockchain Week
Hong Kong, Hong Kong, April 22nd, 2026, Chainwire

CEX.IO selects OpenPayd to power real-time settlements for institutional clients
London, United Kingdom, April 22nd, 2026, Chainwire
These Stocks Could Rip into the Close
As the market barrels into the final hour of trading, momentum is clustering around a powerful trio of themes, AI infrastructure, next-gen materials, and sustainable agriculture. $KBLB, $LOCL, $MRVL, $POET, $PALI, $FFAI
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach
By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader Soligenix (NASDAQ: SNGX) is emphasizing the strategic importance of patient-centric drug development, as outlined by CEO Christopher J. Schaber in a Clinical Leader guest column, which explores how reformulating therapies can improve access, adherence, and real-world viability. Drawing on the company’s experience with SGX945, Schaber explains that […]
Latest
Apr 21, 2026, 2:43 PM
Apr 21, 2026, 1:46 PM
Apr 21, 2026, 1:02 PM
Apr 21, 2026, 12:25 PM
More News

Vantage Introduces an Enhanced App with a Seamless All-in-One Trading Experience
Apr 21, 2026, 10:26 AM



